GSK - GSK Share Forecast, Price & News

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GSK in the last year. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" GSK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
View GSK analyst ratings or view top-rated stocks.

9 brokerages have issued 12-month price targets for GSK's stock. Their GSK share price forecasts range from GBX 1,500 to GBX 2,100. On average, they anticipate the company's stock price to reach GBX 1,805.83 in the next year. This suggests a possible upside of 34.3% from the stock's current price.
View analysts price targets for GSK or view top-rated stocks among Wall Street analysts.

GSK's stock was trading at GBX 1,606.60 at the start of the year. Since then, GSK stock has decreased by 16.3% and is now trading at GBX 1,344.40.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our GSK earnings forecast.

GSK plc (LON:GSK) announced its quarterly earnings data on Wednesday, July, 29th. The company reported $56.90 earnings per share for the quarter.

GSK announced a dividend on Wednesday, July 27th. Investors of record on Thursday, August 18th will be paid a dividend of GBX 16.25 per share on Thursday, October 6th. This represents a dividend yield of 0.93%. The ex-dividend date of this dividend is Thursday, August 18th. This is an increase from the stock's previous dividend of GBX 14. The official announcement can be seen at this link.
Read our dividend analysis for GSK.

GSK (LON:GSK) pays an annual dividend of GBX 86 per share and currently has a dividend yield of 6.35%. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 7,543.86%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for GSK.

Based on aggregate information from My MarketBeat watchlists, some companies that other GSK investors own include AstraZeneca (AZN), General Electric (GE), Royal Dutch Shell (RDSB), Vodafone Group Public (VOD), Intel (INTC), NVIDIA (NVDA), Johnson & Johnson (JNJ), AT&T (T), Barclays (BARC) and Gilead Sciences (GILD).

GSK trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

Shares of GSK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of GSK stock can currently be purchased for approximately GBX 1,344.40.

GSK (LON:GSK) has a market capitalization of £54.68 billion and generates £37.24 billion in revenue each year.

The company employs 90,096 workers across the globe.

GSK's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The official website for the company is www.gsk.com. The company can be reached via phone at +44-20-80475000.